Conference Home

Scientific Agenda

Accommodations & Travel

Sponsorship


The Canadian Immuno-Oncology Summit 2018 is a one-day event being held Thursday, November 1st, 2018 in Toronto, Ontario.
The Summit will be chaired by Dr. Sunil Verma and Dr. Rosalyn Juergens.

This year's program will cover a variety of important topics examining advances in immuno-oncology and also explore topics that pertain to clinical practice, adverse event management and the pharmacoeconomics of novel therapies. This event will draw from experts in immuno-oncology from across North America. 


Learning Objectives:

  • To review basic principles of immuno-oncology as well as key advances in different tumour sites
  • To discuss best practices and practical implications for patient management
  • To examine adverse event management of novel therapies
  • To discuss the pharmacoeconomics of these agents

FEES

 

EARLY

*Ends September 30, 2018

REGULAR

Physicians

$155

$195

Nurses/Pharmacists/Allied Healthcare Providers

$80

$105

Residents/Students

$25

$25


About the Chair:

Dr. Sunil Verma, MD, MSEd, FRCPC is a Professor at the University of Calgary and Medical Director at the Tom Baker Cancer Centre. He completed his internal medicine and medical oncology training at the University of Alberta and then went on to a fellowship in breast cancer at the University of Toronto. He also completed his Master of Science in medical education from the University of California during his fellowship years.

Dr. Verma’s main clinical interests are in the treatment and management of breast cancer and lung cancer. He also has key research interests in neoadjuvant and endocrine treatment of breast cancer, reducing toxicity of systemic treatment, and developing novel therapies in breast and lung cancer. He has won numerous teaching awards and has also been recognized with many awards for his mentorship.

Dr. Verma has led and created a number of national and international educational projects in oncology. He is well published, including being first author in New England Journal of Medicine along with other prestigious journals and is recognized internationally for his research and education leadership in breast and lung cancer. He is a member of several professional societies including ASCO, the Canadian Association of Medical Oncologists, and the Canadian Medical Association.

Dr. Rosalyn Juergens, BS, MD, PhD is a Medical Oncologist at the Juravinski Cancer Centre in Hamilton, Ontario, Canada where she specializes in lung, stomach and esophageal cancers. She is also an Associate Professor in the Department of Oncology at McMaster University. Her research focus has been in developmental therapeutics with a concentration on Phase I and II clinical trials. She has several research interests. She has research expertise in functional imaging and has conducted phase I clinical trials with novel imaging probes. Her work in developmental therapeutics has focused on epigenetics, immuno-oncology and targeted therapies.


Contact Information

For more information, please send requests to  laura@oncologyeducation.com.

Oncology Clinical News

Roche Takes Tecentriq Hit On Survival Data


Read full article.

Powered by OBR Oncology